Single-institution, single-arm, open-label phase II basket study of mutation and/or elevated hedgehog (Hh) expression-directed smoothened inhibitor sonidegib in patients with advanced solid malignancies
ACTRN 12623001216606 Brief Summary The purpose of the study is to investigate…
Read more arrow_forward